Dr. Quazi T. H. Shubhra earned his PhD in Nanotechnology from the University of Pannonia, Hungary, as a Marie Curie fellow in October 2014, and completed postdoctoral research in Japan and China, where he expanded his expertise in innovative drug delivery systems for cancer therapy. He holds a BSc and MSc in Applied Chemistry from the University of Dhaka, Bangladesh.

Currently, Dr. Shubhra is a Distinguished Professor at Renmin Hospital of Wuhan University, China, and an Assistant Professor at the University of Silesia, Poland. He has published over 50 SCI articles in top-tier journals including Nature Reviews Chemistry, Nature Chemistry, Advanced Science, Signal Transduction and Targeted Therapy, Cell Metabolism, and Trends in Cancer focuses on the development of cutting-edge nanotechnology applications in drug delivery.

Dr. Shubhra’s contributions to science are recognized globally through prestigious accolades such as the Marie Curie PhD and JSPS postdoc fellowships, along with other awards. He has actively participated in high-profile scientific forums, including the 65th Lindau Nobel Laureate Meeting in Germany and the 8th HOPE Meeting in Japan.

Dr. Shubhra is an active contributor to the scientific community, serving as Associate Editor of the Journal of Translational Medicine (IF 6.1), Youth Editor for Research (IF 8.5) and The Innovation Life, and Editorial Board Member for many journals like BMC Methods, Discover Nano, Discover Chemistry, etc. A dedicated reviewer for high-impact publications, he advances nanomedicine through innovative therapeutic strategies and mentorship of future scientific leaders.